ORKA vs VTRS · $4.27B cap vs rev $7.27B
Oruka Therapeutics, Inc. (ORKA) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
ORKA does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
ORKA currently screens at market cap $4.27B. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the ORKA and VTRS stock pages for the full models.
Not investment advice.